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Background. Scrub typhus, caused by Orientia tsutsugamushi, is a major cause of acute febrile illness in children in the rural 
tropics.
Methods. We recruited 60 febrile pediatric patients with a positive scrub typhus rapid diagnostic test result and 40 healthy 
controls from Chiang Rai Province in northern Thailand. Diagnosis was confirmed by the detection of (1) O. tsutsugamushi–specific 
DNA in blood or eschar samples with a polymerase chain reaction assay, (2) a fourfold rise in immunoglobulin M (IgM) titer to 
≥1:3200 in paired plasma samples with an indirect immunofluorescence assay (IFA), or (3) a single IgM titer of ≥1:3200 in an acute 
plasma sample with an IFA. Demographic, clinical, and laboratory data were collected, and patients were followed up for 1 year.
Results. Diagnosis was confirmed in 35 (58%) of 60 patients, and all controls tested negative for scrub typhus. Patients with 
confirmed scrub typhus had clinical symptoms, including fever (35 of 35 [100%]), eschar (21 of 35 [60%]), cough (21 of 35 [60%]), 
tachypnea (16 of 35 [46%]), lymphadenopathy (15 of 35 [43%]), and headache (14 of 35 [40%]). Only 4 (11%) of 35 patients received 
appropriate antibiotic treatment for scrub typhus before admission. The median fever-clearance time was 36 hours (interquartile 
range, 24–53 hours). Complications observed include hepatitis (9 of 35 [26%]), severe thrombocytopenia (7 of 35 [20%]), pneumo-
nitis (5 of 35 [14%]), circulatory shock (4 of 35 [11%]), and acute respiratory distress syndrome (3 of 35 [9%]). Treatment failure, 
defined by failure to defervesce within 72 hours of antibiotic treatment initiation, was noted in 8 (23%) of 35 patients, and 1 (3%) of 
the 35 patients died. No evidence of relapse or reinfection was found.
Conclusion. Pediatric scrub typhus in northern Thailand is often severe and potentially fatal with delays in treatment a likely 
contributing factor. Additional studies to investigate the bacterial, pharmacologic, and immunologic factors related to treatment 
outcome along with measures to improve public awareness should be prioritized.
Keywords. children; Orientia tsutsugamushi; outcomes; scrub typhus; Thailand.
Scrub typhus, a potentially severe but treatable infection caused 
by the obligate intracellular bacterium Orientia tsutsugamushi, is 
a major cause of acute nonmalarial febrile illness in children in 
the rural tropics [1–3]. Transmission occurs when trombiculid 
mites, in their larval stage, feed on humans [4]. The disease is en-
demic over an area of at least 13,000,000 km2 of the Asia Pacific 
region although recent reports suggest it is much more wide-
spread [5, 6]. Historically, the burden of scrub typhus in children 
has been high. The proportion of pediatric cases ranged from 
50% to 74% in southern China and Taiwan, respectively,  while 
52% of children were found to be seropositive in central Thailand 
[7–9]. Children are less likely to have preexisting immunity and 
are at greater risk of developing severe disease [10, 11].
The treatment of scrub typhus involves the use of an anti-
biotic such as doxycycline, chloramphenicol, azithromycin, 
or rifampicin. A  rapid response, signified by fever resolution, 
was understood to be characteristic of the disease. However, 
reports have emerged from studies in northern Thailand in 
which delayed defervescence and severe disease were observed 
in both adults and children despite treatment with appropriate 
antibiotics [12, 13]. This finding contrasts with those of 2 other 
pediatric studies in the same region in which doxycycline and 
chloramphenicol were uniformly effective in treating scrub ty-
phus [14, 15]. Although these findings have been attributed to 
drug resistance, supportive evidence is lacking, and the deter-
minants of treatment outcome remain uncharacterized.
Studies of pediatric scrub typhus in which stringent di-
agnostic criteria were used are scarce. The lack of access to 
diagnostic tests, such as the gold-standard indirect immuno-
fluorescence assay (IFA), polymerase chain reaction (PCR) 
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assay, and in vitro culture, have contributed to this scarcity. 
Recent studies from the endemic area are limited by their retro-
spective nature, insufficient follow-up, lack of a control group, 
heterogeneity in the diagnostic criteria used, and frequent reli-
ance on inadequately validated diagnostic assays [14–20].
All of these assays have inherent weaknesses [21]. The per-
ceived accuracy of serological tests (eg, enzyme-linked immu-
nosorbent assays, IFAs) depend on the antigenic complement 
of the assay with the infecting bacterial strain and the extent of 
residual antibodies in the population within areas of endemicity 
[22, 23]. PCR assays and culture are specific, but their sensitivity 
can vary, depending on the quality of the samples, disease time 
point, and bacterial load [23]. Moreover, the limited validation 
studies performed to date have been focused on adult samples, 
which results in a degree of uncertainty regarding the accuracy 
of these assays for children.
In this study, we aimed to characterize pediatric scrub ty-
phus and explore the determinants of treatment outcome in a 
region for which it was reported to be suboptimal. We inves-
tigated the use of robust and validated diagnostic criteria that 
had not been applied to children previously. To achieve these 
goals, a prospective observational study in children with scrub 
typhus in northern Thailand was performed, incorporating a 
prolonged follow-up period and healthy control group from the 
same region.
MATERIALS AND METHODS
Ethics and Setting
Ethical approval for this study was obtained from the ethics 
committees of Chiang Rai Prachanukroh Hospital and Chiang 
Rai Provincial Public Health Office, Ministry of Public Health 
(Thailand), Faculty of Tropical Medicine (Mahidol University, 
Bangkok, Thailand), and University of Oxford (Oxford Tropical 
Research EC, Oxford, United Kingdom). This study was regis-
tered at ClinicalTrials.gov (identifier NCT02398162).
Chiang Rai Prachanukroh Hospital is located in Chiang Rai 
Province, the northernmost province of Thailand bordering 
Myanmar and Laos. It is the main provincial hospital with a 
defined catchment area but also accepts patients from outlying 
healthcare facilities who require escalation of care. The prov-
ince has a high burden of scrub typhus; the population of 1.25 
million consists predominantly of ethnic Thais, and 12% to 13% 
belong to a hill tribe or other minority ethnic group [24].
Patients, Study Schedule, and Sample Collection
From July 2015 to August 2016, we prospectively recruited 
60 children aged <18 years who were admitted to Chiang Rai 
Prachanukroh Hospital with fever (temperature > 37.5°C) 
or history of fever within the preceding 14  days, had a posi-
tive scrub typhus immunoglobulin M (IgM) rapid diagnostic 
test (RDT) result, were not diagnosed with or being treated for 
tuberculosis, were not immunocompromised, and were not 
pregnant. Written informed consent was obtained from the 
parent or guardian, as was the child’s assent if he or she was 
aged ≥7 years. Demographic, clinical, and laboratory data were 
collected individually on study case-record forms. Findings 
from chest radiography (CXR), if performed, were recorded. 
Fever-clearance time (FCT) was defined as the time taken from 
the initiation of appropriate antibiotic treatment (doxycycline, 
chloramphenicol, tetracycline, azithromycin, or rifampicin) to 
defervescence (temperature ≤ 37.5°C) with the temperature 
remaining at ≤37.5°C for ≥24 hours after that point. Treatment 
failure was defined as an FCT of greater than 72 hours after the 
initiation of appropriate antibiotic treatment. Relapse or rein-
fection was defined as a return of fever and other symptoms 
compatible with scrub typhus along with confirmatory labora-
tory diagnosis, as described below.
Blood samples were collected at baseline and at the 2-, 
12-, and 52-week follow-up time points. Blood was col-
lected in ethylenediaminetetraacetic acid (EDTA) and clot-
ted-blood tubes and processed to obtain aliquots of whole 
blood, plasma, buffy coat, and serum. If present, an eschar 
swab or crust was collected in 95% ethanol. Samples were 
stored at −80°C and transported to Bangkok for diagnostic 
processing. During the follow-up period, patients were also 
clinically assessed for additional illnesses, and their treat-
ment was recorded. Recruitment and follow-up were com-
pleted by August 2017.
During the study period, we also recruited 40 children from 
the community to act as controls. These children were either 
siblings of patients or children who were living in areas in which 
scrub typhus cases had occurred. All of them were healthy, none 
reported a past history of scrub typhus infection, and almost 
all of them had no knowledge of the disease. Written informed 
consent and assent were obtained. Demographic data and blood 
samples were collected for diagnostic, hematology, and bio-
chemistry tests.
Diagnostic Assays and Attribution of Diagnosis
The scrub typhus Detect IgM rapid test (InBios International, 
Inc, Seattle, Washington), an immunochromatographic-based 
test that uses recombinant 56-kDa type-specific antigen (TSA) 
of the Karp, Kato, Gilliam, and TA716 strains of O. tsutsuga-
mushi, was used for screening [25]. The gold-standard IFA was 
used to detect IgM antibody titers in paired plasma samples (or 
in admission samples, only when convalescent samples were 
unavailable) against pooled O. tsutsugamushi antigens from the 
Karp, Kato, Gilliam, and TA716 strains, as previously described 
[26]. A  validated diagnostic IFA cutoff titer of ≥1:3200 in a 
single acute-phase sample or a greater than fourfold rise to 
≥1:3200 in a convalescent-phase sample was used to determine 
positivity [27].
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O. tsutsugamushi–specific PCR assays were performed as 
previously described [28–30]. In brief, DNA extraction from 
whole blood, buffy coat, or noninvasive eschar samples (if 
applicable) was performed. Then, a real-time PCR assay was 
performed to detect the 47-kDa htra gene in duplicate and, if 
the result was positive, the nested 56-kDa TSA gene PCR assay 
was performed.
In controls, PCR assays were performed as already described, 
and serological testing included a screening enzyme-linked im-
munosorbent assay with a ≥0.5 net optical density cutoff fol-
lowed by the IFA as appropriate [31]. The diagnosis of scrub 
typhus was made on the basis of robust criteria previously 
described and updated with the following validated IFA cutoff 
titers: (1) a positive PCR or culture result from either a blood 
or eschar sample, (2) a fourfold rise in the IgM titer to ≥1:3200 
in paired serum or plasma samples, or (3) a single IgM titer of 
≥1:3200 in an acute-phase serum or plasma sample [27, 32]. 
Diagnostic PCR and serology assays were performed in the 
main laboratory facilities at Mahidol-Oxford Tropical Medicine 
Research Unit in Bangkok, Thailand.
Statistical Analysis
Proportions, percentages, and averages were calculated 
(medians and interquartile ranges [IQRs], unless specified). 
Comparisons of demographic, exposure, and laboratory vari-
ables between the patient and control groups were performed 
using the Mann-Whitney U test, the Pearson’s χ2 test, or the 
Fisher’s exact test, as appropriate. Seasonality was assessed 
by calculating proportions and their 95% confidence interval 
(CI) and performing 2-sample tests of proportions. FCTs were 
plotted using a Kaplan–Meier survival curve. Treatment failure 
was analyzed using logistic regression. Analyses were per-
formed using Stata 15 software (College Station, Texas).
RESULTS
Diagnostic, Demographic, and Epidemiologic Findings
Of the 60 pediatric patients recruited for this study, 35 had con-
firmed scrub typhus infection. The PCR result was positive in 
31 patients, whereas with the IFA, 34 patients had a detectable 
scrub typhus group IgM titer higher than the specified cutoffs. 
We found good concordance between the diagnostic assays; 
30 (97%) of the 31 PCR-positive patients were found also to 
be positive for scrub typhus IgM. All 39 controls for whom a 
sample was available tested negative for scrub typhus (an insuf-
ficient amount of blood was collected for 1 control).
Demographic and exposure history data are shown in 
Supplementary Table 1. The controls were older and more likely 
to identify as Thai, whereas the patients were more likely to be 
younger, identify as belonging to a hill tribe, and have had more 
contact with chickens and hilly areas before admission. Patients 
who belonged to a hill tribe (31 of 35 [89%]) were mostly 
Akha (20 of 31 [65%]) or Lahu (7 of 31 [23%]), and the Karen, 
Hmong, Lisu, and Yao or Mien tribes contributed 1 (3%) of 31 
patients each. Hill-tribe distribution was less skewed in the con-
trols (Karen, 9 of 24 [38%]; Akha, 8 of 24 [33%]; Yao or Mien, 
4 of 24 [17%]; Lahu, 3 of 24 [13%]; unknown, 1 of 24 [4%]; and 
both Karen and Akha, 1 of 24 [4%]).
The majority of patients with scrub typhus were from the 
western, rural and mountainous region of the province, and 
we found some clustering, suggestive of multiple high-trans-
mission foci. A larger proportion of patients were admitted be-
tween June and November than between December and May 
(33 and 2 patients, respectively) (0.94 [95% CI, 0.87 to 1.02] and 
0.06 [95% CI, −0.02 to 0.13], respectively; P < .001). This period 
coincided with the wet and early winter seasons, in northern 
Thailand.
Clinical, Laboratory, and Radiologic Features
In Table 1, clinical features of the patients on admission are 
shown. All the patients had a fever or history of fever before 
admission. Patients who were admitted directly to the provin-
cial hospital were febrile for a shorter period of time (6  days 
[IQR, 3–9 days]) than those who were transferred from another 
hospital (10 days [IQR, 7–11 days]) (P = .006). Other common 
findings included the presence of an eschar (60%), cough (60%), 
lymphadenopathy (43%), headache (40%), rash (34%), vom-
iting (31%), and hepatomegaly (31%). Eschars were detected 
most frequently on the external genitalia (exclusively in boys) 
and the head and inguinal regions. A temperature of >37.5°C 
(31 of 35 [89%]), tachypnea (16 of 35 [46%]), and tachycardia 
(11 of 35 [31%]) were common vital sign features on admission.
Laboratory and CXR results for patients and available lab-
oratory results for the controls are also listed in Table 1. The 
patients with scrub typhus had lower platelet, lymphocyte, and 
eosinophil counts than the controls. Although the patients 
also had lower hemoglobin and hematocrit levels, these find-
ings might be confounded by the age difference between the 
groups. Elevated aspartate aminotransferase (AST), alanine 
aminotransferase, and C-reactive protein levels along with low 
albumin and alkaline phosphatase levels were the main bio-
chemical findings in the patients. In patients for whom CXR 
results were available, normal appearances (12 of 21 [57%]) 
and pulmonary infiltrates (9 of 21 [43%]) were the main find-
ings. Other microbiological tests performed at the discretion of 
local clinicians (blood, urine, stool, sputum, and cerebrospinal 
fluid cultures; malaria film; dengue and leptospirosis RDTs) all 
yielded negative or nonsignificant results.
Treatments, Complications, and Outcomes
The treatments given are outlined in Supplementary Table 
2. Preadmission antibiotics were given to 22 (63%) of the 35 
patients, but only 4 (18%) of these 22 patients received ap-
propriate antibiotics for scrub typhus (chloramphenicol, 
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Table 1. Clinical, Laboratory, and Radiographic Features on Admission of Pediatric Patients With Scrub Typhus and Comparative Laboratory Results for 
the Healthy Control Group
Clinical Feature Patients With ST (n = 35) Healthy ST-Exposed Controls (n = 40) P a
Length of hospital stay (median [IQR]) (days) 5 (4–7) — —
Duration of fever before admission (median [IQR]) (days) 7 (5–10) — —
Transferred from another hospital (n [%]) 14 (40) — —
Fever (>37.5°C on or during admission) (n [%]) 35 (100) — —
Temperature on admission (median [IQR]) (°C) 38.9 (38.0–39.5) — —
Rigors (n [%]) 5 (14) — —
Eschar (n [%]) 21 (60) — —
Eschar location (n [%])  — —
 External genitalia 9 (43) — —
 Head 4 (19) — —
 Inguinal region 3 (14) — —
 Chest 2 (10) — —
 Axillary region 1 (5) — —
 Neck 1 (5) — —
 Shoulder 1 (5) — —
 Buttock 1 (5) — —
 Waistline 1 (5) — —
Rash (n [%]) 12 (34) — —
Rash type (n [%])  — —
 Petechial 5 (42) — —
 Maculopapular 5 (42) — —
 Macular 2 (17) — —
Cough (n [%]) 21 (60) — —
Dyspnea (n [%]) 6 (17) — —
Lung crepitations (n [%]) 6 (17) — —
Intubated on or within 24 h of admission (n [%]) 5 (14) — —
Epistaxis (n [%]) 1 (3) — —
Hemoptysis (n [%]) 0 (0) — —
Nausea (n [%]) 3 (9) — —
Vomiting (n [%]) 11 (31) — —
Diarrhea (n [%]) 10 (29) — —
Abdominal pain (n [%]) 7 (20) — —
Jaundice (n [%]) 0 (0) — —
Hepatomegaly (n [%]) 11 (31) — —
Splenomegaly (n [%]) 3 (9) — —
Gum bleeding (n [%]) 0 (0) — —
Hematemesis (n [%]) 0 (0) — —
Conjunctivitis (n [%]) 8 (23) — —
Subconjunctival hemorrhage (n [%]) 2 (6) — —
Retro-orbital pain (n [%]) 1 (3) — —
Tinnitus (n [%]) 0 (0) — —
Deafness (n [%]) 0 (0) — —
GCS (median [IQR]) 15 (15–15) — —
Headache (n [%]) 14 (40) — —
Neck stiffness (n [%]) 3 (9) — —
Seizures (n [%]) 3 (9) — —
Confusion (n [%]) 3 (9) — —
Vertigo (n [%]) 1 (3) — —
Arthralgia (n [%]) 0 (0) — —
Myalgia (n [%]) 4 (11) — —
Lymphadenopathy (n [%]) 15 (43) — —
Hemoglobin (median [IQR]) (g/dL) 11.3 (10.3–11.9) 13.2 (12.5–14.1) <.001b
Hematocrit (median [IQR]) (%) 34.4 (31.7–36.7) 40.8 (38.8–43.8) <.001b
Platelets (median [IQR]) (×103/mm3) 107 (58–178) 290 (256–355) <.001b
White blood cell count (median [IQR]) (×103/mm3) 8.1 (5.9–11.5) 8.0 (6.9–9.7) .733
Neutrophils (median [IQR]) (×103/mm3) 4.2 (3.1–7.2) 4.7 (3.2–5.5) .742
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doxycycline, azithromycin, or rifampicin). In contrast, all the 
patients received antibiotics effective against scrub typhus 
during their admission, which is a testament to the experience 
and awareness of local pediatricians at the provincial hospital. 
Doxycycline was used in 30 (86%) of 35, chloramphenicol in 
14 (40%) of 35, azithromycin in 3 (9%) of 35, and rifampicin in 
3 (9%) of 35 patients.
A large proportion of the patients (14 of 35 [40%]) developed 
a complication, as outlined in Table 2; most of these patients 
(11 of 14 [79%]) had more than 1 systemic complication of 
scrub typhus with a degree of overlap between the complica-
tions observed. For example, 3 patients with pneumonitis de-
veloped acute respiratory distress syndrome, and 1 patient had 
acute myocarditis that progressed to circulatory shock. Despite 
the severe nature of scrub typhus in this study, the majority of 
patients recovered; 1 patient with multiorgan failure died.
The median FCT for this pediatric scrub typhus cohort was 
36 hours (IQR, 24–53 hours), and the median headache-clear-
ance time was 36 hours (IQR, 24–48 hours). The proportion 
of febrile patients over time is shown in Figure 1. Treatment 
failure, based on prolonged FCT, was observed in 8 (23%) of 
35 patients, 7 of whom had unresolved fever and persisting 
complications and 1 of whom died. The mortality rate was 3% 
in this study. The majority of patients completed the study (33 
of 35 [94%]); 1 patient died and 1 patient missed the 52-week 
follow-up because of migration. We encountered no clinical or 
laboratory-confirmed (using PCR and IFA) case of relapse or 
reinfection during the entire follow-up period.
Univariate logistic regression analysis was performed to de-
termine variables associated with treatment failure (results are 
listed in Table 3). During the study period, chloramphenicol was 
exclusively administered intravenously in patients, which might 
have selected for those with severe disease (ie, those who were 
intubated and unable to take oral antibiotics), which increased 
the likelihood of treatment failure. In contrast, we found no 
Lymphocytes (median [IQR]) (×103/mm3) 1.7 (1.3–3.4) 2.7 (2.1–3.1) .024b
Monocytes (median [IQR]) (×103/mm3) 0.5 (0.2–0.7) 0.6 (0.4–0.7) .357
Eosinophils (median [IQR]) (×103/mm3) 0.0 (0.0–0.0) 0.2 (0.1–0.5) <.001b
Blood urinary nitrogen (median [IQR]) (mg/dL) 9.8 (7.1–11.6) 10.0 (9.4–11.8) .345
Creatinine (median [IQR]) (mg/dL) 0.43 (0.37–0.55) 0.52 (0.42–0.59) .146
Sodium (median [IQR]) (mmol/L) 131 (129–134) — —
Potassium (median [IQR]) (mmol/L) 3.5 (3.3–4.0) — —
Chloride (median [IQR]) (mmol/L) 100 (97–105) — —
Globulin (median [IQR]) (g/dL) 3.1 (2.6–3.5) 3.2 (3.0–3.6) .120
Albumin (median [IQR]) (g/dL) 2.9 (2.6–3.3) 4.4 (4.2–4.5) <.001b
Bilirubin direct (median [IQR]) (mg/dL) 0.2 (0.1–0.2) 0.2 (0.1–0.2) .508
Bilirubin total (median [IQR]) (mg/dL) 0.4 (0.3–0.5) 0.4 (0.3–0.6) .799
AST (median [IQR]) (IU/L) 140 (78–203) 23 (19–28) <.001b
ALT (median [IQR]) (IU/L) 69 (44–111) 14 (11–18) <.001b
ALP (median [IQR]) (IU/L) 162 (107–224) 229 (159–310) .032b
CRP (median [IQR]) (µg/mL) 44 (22–88) <5 (<5–<5) <.001b
CXR performed (n [%]) 21 (60) — —
CXR findings  — —
 Normal (n [%]) 12 (57) — —
 Pulmonary infiltrates (n [%]) 7 (33) — —
 Pulmonary infiltrates and edema (n [%]) 2 (10) — —
Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; CXR, chest radiography; GCS, Glasgow Coma Scale; IQR, interquartile range; ST, scrub typhus.
aThe analysis was performed using the Mann–Whitney U test.
bStatistically significant result.
Table 1. Continued
Clinical Feature Patients With ST (n = 35) Healthy ST-Exposed Controls (n = 40) P a
Table 2. Complications Observed in Patients With Scrub Typhus 
Complication Patients With Complication (n [%])
Severe hepatitisa 9 (26)
Severe thrombocytopeniab 7 (20)
Pneumonitis 5 (14)
Circulatory shockc 4 (11)
Acute respiratory distress syndromed 3 (9)
Acute kidney injurye 2 (6)
Hematologic abnormalities consistent with DICf 2 (6)
Meningitisg 2 (6)
Meningoencephalitish 1 (3)
Myocarditisi 1 (3)
Upper gastrointestinal hemorrhage 1 (3)
Abbreviation: DIC, disseminated intravascular coagulation.
aAspartate aminotransferase or alanine aminotransferase level ≥5 times the upper limit of normal.
bPlatelet count of <50 × 103/mm3.
cSevere circulatory failure that required inotropic and vasopressive support.
dAcute respiratory failure, hypoxia, and bilateral infiltrates seen with chest radiography.
eClinically denoted (reduced urine output) (elevated creatinine level in 1 case).
fHematologic abnormalities consistent with DIC, tentative diagnosis based on thrombocytopenia, prolonged 
prothrombin time, and prolonged activated partial thromboplastin time.
gClinical features (meningism), cerebrospinal fluid leukocytosis in 1 case.
hClinical features (confusion, disorientation, and visual hallucination), cerebrospinal fluid leukocytosis.
iReduced ejection fraction and biventricular enlargement on transthoracic echocardiogram, elevated troponin 
I level.
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evidence of treatment failure associated with doxycycline use 
during admission (only oral formulations were available); the 
use of doxycycline was associated with treatment success (odds 
ratio, 0.1 [95% CI, 0.0–1.0]; P  =  .052). Hepatomegaly, higher 
total bilirubin level, and severe hepatitis (mainly raised AST 
level [≥5 times the upper limit of normal]) were also signifi-
cantly associated with treatment failure. Multivariate logistic 
regression analysis was performed by using severe hepatitis 
as the representative hepatic variable (to minimize the risk of 
multicollinearity) along with transfer from another hospital and 
chloramphenicol use during admission (Table 3). Severe hep-
atitis remained significantly predictive of treatment failure in 
this model.
DISCUSSION
In this report, we describe a well-characterized cohort of pedi-
atric patients with scrub typhus, according to robust diagnostic 
criteria, and a comparatively healthy control group with a pro-
longed follow-up period of 1 year in northern Thailand. Scrub 
typhus occurs more often in rural mountainous areas and 
disproportionately affects the hill-tribe population (particu-
larly the Akha and Lahu). Disease seasonality reflects previous 
findings in adults from the same province [33]. An eschar was 
present in 60% of our patients, similar to rates previously re-
ported, which reflects the absent or limited preexisting immu-
nity in children compared to that in adults [10, 13–15]. Cough, 
tachypnea, and lymphadenopathy in Thai children with scrub 
typhus have been reported previously, although hepatomegaly 
was less common in our cohort [14, 15, 17]. Thrombocytopenia, 
a raised C-reactive protein level, a low albumin level, and ele-
vated hepatic enzyme levels (particularly AST) were common 
findings; the latter was shown previously to be useful for dif-
ferentiating scrub typhus from other causes of undifferentiated 
fever, such as dengue, in adults [33, 34].
The accuracy of the RDT used for screening in this pediatric 
study was disappointing; many false-positive results occurred 
despite promising results when it was validated using adult 
samples from Chiang Rai [25]. The development of an accu-
rate, cost-effective diagnostic test, validated for adults and chil-
dren throughout the region of endemicity, clearly remains a key 
diagnostic goal.
Appropriate antibiotics were administered once the patients 
arrived at the provincial hospital. However, antibiotics used 
in the community and other healthcare facilities frequently 
excluded coverage for scrub typhus and other rickettsial dis-
eases, an observation also made in adults [33]. As a consequence, 
effective treatment was delayed in many patients, which might 
have contributed to the high complication (40%) and treat-
ment failure (23%) rates in our study. Disease awareness among 
healthcare workers and the general population throughout the 
region must improve. Markers of hepatic dysfunction, previ-
ously shown to be associated with disease severity, were sig-
nificantly associated with treatment failure in our study [34]. 
Figure 1. Kaplan–Meier survival curve for fever clearance. The vertical 
dashed line indicates the 72-hour fever-clearance time treatment-failure 
cutoff.
Table 3. Variables Significantly Associated With Treatment Failure in Logistic Regression Analysesa
Variable OR 95% CI P
Univariate logistic regression analysis
 Transferred from another hospital 7.1 1.2–43.1 .033c
 Hepatomegaly 13.2 2.0–85.8 .007c
 Severe hepatitisb 24 3.2–177.4 .002c
 Bilirubin total (mg/dL) 106.6 2.2–5191.9 .019c
 Chloramphenicol use during admission 20 2.1–192.7 .010c
Multivariate logistic regression analysisa    
 Transferred from another hospital 2.7 0.2–29.1 .420
 Severe hepatitis 13.1 1.4–119.9 .023c
 Chloramphenicol use during admission 7.6 0.6–102.7 .128
Abbreviations: CI, confidence interval; OR, odds ratio.
aVariables included in the multivariate logistic regression analysis limited to “transferred from another hospital,” “chloramphenicol use during admission,” and “severe hepatitis” as the representative hepatic variable to minimize 
the risk of multicollinearity. Odds ratio for the multivariate log regression analysis is adjusted OR.
bDefined as an aspartate aminotransferase or alanine aminotransferase level of ≥5 times the upper limits of normal.
cStatistically significant result.
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Specifically, severe hepatitis, as defined by a markedly elevated 
AST or alanine aminotransferase level (ALT), might be predic-
tive of treatment failure in children.
It is likely that factors beyond delays in recognition and 
treatment contributed to the high treatment failure rates. 
Bacterial factors, such as the diversity of virulence of infecting 
O. tsutsugamushi strains, have been described [6, 35]. Tentative 
findings of antibiotic resistance from northern Thailand have 
been reported and widely cited but have yet to be verified inde-
pendently [12]. Indeed, recent in vitro antibiotic-susceptibility 
testing of allegedly resistant O. tsutsugamushi strains failed to 
provide supportive evidence of resistance [36]. Improving our 
understanding of the virulence of O. tsutsugamushi and its in-
fective life cycle and interstrain variability is crucial for solv-
ing the decades-old conundrum of treatment failure in patients 
with scrub typhus infection. Recent studies have begun to ex-
plore these fundamentals [37, 38].
Pharmacologic factors, including the mechanisms of ac-
tion and pharmacokinetics of the antibiotics used for scrub ty-
phus, also contribute to treatment outcome [39]. Specifically, 
drug concentrations achieved within cells (such as peripheral 
blood mononuclear cells) with current antibiotic doses warrant 
further study [40]. Host immunity has been shown to be pro-
tective in humans and nonhuman primates [10, 11]. However, 
immunity is short-lived; protection from heterologous and ho-
mologous strains is limited to a few months and 1 to 2 years, 
respectively [10, 11]. No vaccine currently provides long-term 
heterologous protection. Determining the immune correlates of 
protection will be key to understanding the effect of preexisting 
immunity on clinical outcome and the development of effective 
vaccines.
Limitations of this study include the demographic mismatch 
between the control and patient groups, which occurred despite 
our efforts to minimize these differences. The patient num-
bers were relatively small but comparable to those in previous 
studies on pediatric scrub typhus. Because of limited resources 
at the time of the study, cultures and susceptibility testing were 
not performed. In addition, the IFA cutoffs used have not been 
validated using pediatric samples. However, good concordance 
between IFA and PCR results in both confirmed and negative 
cases of scrub typhus suggest that the diagnostic criteria we 
used were appropriate for this population and region.
CONCLUSION
Scrub typhus remains a severely neglected infectious disease 
despite growing evidence of its importance in the rural trop-
ics. Previous studies in children have been limited by absent or 
short follow-up, lack of a control group, and reliance on unval-
idated diagnostic tests. The results of our study show the value 
of using diagnostic criteria that combine both validated bacte-
rial and antibody-based assays to greatly increase the certainty 
of diagnosis. Pediatric scrub typhus infection in northern 
Thailand is often severe and potentially fatal. Additional studies 
of the bacterial, pharmacologic, and immunologic factors re-
lated to treatment outcome, along with measures to improve 
public awareness of this disease, should be prioritized.
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Supplementary materials are available at Journal of the Pediatric Infectious 
Diseases Society online.
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